Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

NCT00783653

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Prof. Dr. med. Walter Fiedler Hamburg, Germany
  • PD Dr. med. Jürgen Krauter Hanover, Germany
  • Dr. Katharina Götze München, Germany
  • Prof. Dr. Helmut R. Salih Tübingen, Germany
View Trial Details
Completed

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

NCT00952588

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site New York, United States
  • Research Site Cleveland, Ohio, United States
View all 45 locations
View Trial Details
Completed

Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00262782

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Klinikum St. Marien Amberg, Germany
  • Internistische Praxis - Arnstadt Arnstadt, Germany
View all 117 locations
View Trial Details
Completed

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

NCT00440726

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Miller Children's Hospital Long Beach, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
View all 24 locations
View Trial Details
Completed

A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT02320487

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Southern Cancer Center - Mobile Mobile, Alabama, United States
  • Ironwood Cancer TX & Rsch Ctrs Chandler, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
View all 26 locations
View Trial Details
Completed

A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia

NCT02071225

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital De Txagorritxu; Servicio de Hematologia Vitoria-Gasteiz, Alava, Spain
  • Hospital General Universitario de Elche; Servicio de Hematologia Elche, Alicante, Spain
  • Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia Badalona, Barcelona, Spain
  • Hospital Mutua de Terrassa; Servicio de Hematologia Terrassa, Barcelona, Spain
View all 21 locations
View Trial Details
Completed

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

NCT00068718

Conditions
Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blood Protein Disorders, +38 more
Locations
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • Universitaet Leipzig Leipzig, Germany
  • University of Torino Torino, Italy
View Trial Details

Related conditions